This review (2016) investigates the risks (safety and toxicity) related to the medical use of ketamine (for depression). The most risk is found at chronic and high doses. arketamine is found to have greater antidepressant effects with a smaller risk of adverse events.
- Published
- Journal
- Neuroscience Bulletin
- Authors
- Ding, Z., Hashimoto, K., Lu, L., Shi, J., Zhang, Y., Zhu, W.